Market snapshot, not real-time
S&P 500 (SPY) $748.62 +0.88% Nasdaq-100 (QQQ) $708.90 +1.85% Dow (DIA) $522.55 +0.89% Russell 2000 (IWM) $295.82 +1.20% 10-Year Treasury (IEF) $93.32 −0.23% Crude Oil (USO) $128.37 +2.28% Gold (GLD) $373.85 +1.70% US Dollar Index (UUP) $28.45 +0.23% Volatility (VXX) $21.29 −3.77% Semiconductors (SMH) $583.24 +4.37% Silver (SLV) $53.36 +4.67% Emerging Markets (EEM) $65.45 +2.97% Bitcoin (BTC) $66,470.13 +1.90% Ethereum (ETH) $1,922.88 +1.00% S&P 500 (SPY) $748.62 +0.88% Nasdaq-100 (QQQ) $708.90 +1.85% Dow (DIA) $522.55 +0.89% Russell 2000 (IWM) $295.82 +1.20% 10-Year Treasury (IEF) $93.32 −0.23% Crude Oil (USO) $128.37 +2.28% Gold (GLD) $373.85 +1.70% US Dollar Index (UUP) $28.45 +0.23% Volatility (VXX) $21.29 −3.77% Semiconductors (SMH) $583.24 +4.37% Silver (SLV) $53.36 +4.67% Emerging Markets (EEM) $65.45 +2.97% Bitcoin (BTC) $66,470.13 +1.90% Ethereum (ETH) $1,922.88 +1.00%

Position · Leveraged / Derivative

GraniteShares 2x Long NBIS Daily ETF (NBIL)

2.06% of book · Avg. cost $9.23 · Return +128.17%

NBIL is a leveraged derivative on NBIS, not an operating company, so a competitor comparison doesn't apply the way it does for NBIS itself — see the NBIS position page and its own comparison.

Read NBIS's Q1 2026 earnings report →

Subscribe to NBIL updates (RSS) →

Thesis StatementNBIL amplifies the Nebius thesis 2x daily for outsized upside on a name already believed in, in exchange for real daily-reset decay risk.

Leveraged exposure, currently within policy cap

My Investment Policy Statement caps the leveraged sleeve at 5% of invested capital. NBIL is 2.78%, comfortably under that cap. I also hold NBIS outright at 1.22% — policy counts leveraged-plus-underlying as concentrated single-name risk, so my real Nebius exposure is somewhat larger than either line suggests on its own, even though neither line is currently in breach. Full writeup in the July letter.

NBIL GraniteShares 2x Long NBIS Daily ETF
AEA Institutional Tear Sheet
2.06% of book · Avg. cost $9.23 · Return +128.17%

Core Thesis

NBIL is a 2x daily-reset leveraged ETF on NBIS; its return case rides entirely on Nebius's own compounding, amplified — I added it for outsized upside on a name I already believed in, and the return has been extraordinary, up nearly 250%, precisely because...

Financial Metrics

  • Price$33.16

Bear Case

NBIS goes through a choppy, volatile stretch — even one that's roughly flat over time — and daily-reset decay compounds losses on both the leveraged position and the double-exposure to NBIS itself.

Investment Thesis

The Thesis
NBIL is a 2x daily-reset leveraged ETF on NBIS; its return case rides entirely on Nebius's own compounding, amplified — I added it for outsized upside on a name I already believed in, and the return has been extraordinary, up nearly 250%, precisely because it's 2x daily leverage on one of my best-performing holdings.
The Catalyst
Continued low-volatility upward trending in NBIS itself — that's the specific condition under which daily-reset leverage compounds favorably rather than decaying, so the catalyst here is really just "NBIS keeps doing what it's been doing."
The Risk
A daily-reset 2x ETF decays in choppy, sideways markets even when the underlying is flat over time — a structurally bad long-term hold no matter how the NBIS thesis itself plays out, which is exactly why I've kept it capped under my 5% leveraged-sleeve limit (currently 2.78%).
The Connection
Part of my AI-infrastructure/compute theme as a leveraged wrapper on NBIS — the riskiest, most amplified expression of that theme in the book.

Pre-Mortem Thesis Invalidation Parameters

Codified in advance, before any of these have happened, so a future decision to hold or exit isn't rationalized in the moment. If a condition below is met, the thesis as written is invalidated and the position gets re-underwritten from scratch — not automatically sold, but automatically questioned.

Metric / EventAutomatic Review Trigger
Leveraged-Sleeve CapPosition exceeds my 5% leveraged-sleeve limit (currently 2.78%) without a rebalancing trim.
Underlying NBIS ThesisAny NBIS-specific trigger below fires — NBIL's return case rides entirely on NBIS, amplified.
Structure2x daily-reset leveraged ETF on NBIS (Nebius Group)
Shares outstanding (fund)3.45M
Expense ratio1.50% (capped by the issuer through December 2026)

P/E, EPS, and PEG don't apply to a leveraged single-stock ETF — its return profile is 2x the daily move of NBIS, not a claim on NBIS's earnings. A 1.50% expense ratio is high relative to a plain index fund like SPY or VOO, which is the ongoing cost of the leverage mechanism itself, separate from the decay risk already disclosed above.

Valuation Logic

There is no independent valuation logic for NBIL beyond NBIS's own — see the NBIS position page and the NBIS Q1 2026 earnings report; the leverage mechanism itself is the entire incremental risk/reward relative to holding NBIS outright.

DCF Sensitivity Tool

A simplified single-stage model for exploring how WACC and terminal growth assumptions move an implied share price — not AEA's own valuation of this stock. Adjust the base cash-flow figure to run your own numbers.

Implied Share Price
Formula: Base FCF/Share × (1 + terminal growth) ÷ (WACC − terminal growth). A real DCF would forecast several years of cash flow explicitly rather than capitalize a single base year in perpetuity — this tool is a simplified illustration of how sensitive that kind of valuation is to two assumptions, not a price target.
$3.89 (52-wk low)$33.16$61.73 (52-wk high)

Why I own it, and the risk it still carries

I added this for amplified upside on a name I already believed in. The return has been extraordinary — up nearly 250% — precisely because it's 2x leverage on one of my best-performing holdings. A recent pullback has actually brought it back under the leveraged-sleeve cap, but the underlying risk hasn't changed: a daily-reset 2x ETF decays in choppy, sideways markets even when the underlying is flat over time, which makes it a bad long-term hold no matter how the thesis on NBIS plays out.

Risk/Reward Profile

Bull CaseBear Case
NBIS keeps compounding on strong, low-volatility trends (where daily-reset decay is minimal), and I keep this comfortably under the 5% cap even as the position recovers.NBIS goes through a choppy, volatile stretch — even one that's roughly flat over time — and daily-reset decay compounds losses on both the leveraged position and the double-exposure to NBIS itself.

Base case: NBIS grinds higher with normal volatility, decay eats a meaningful chunk of the theoretical 2x return over any multi-month holding period, and I keep monitoring the combined NBIL/NBIS exposure against policy regardless of how the underlying performs.

Download this position's data

Fundamentals, scenario matrix, and risk/reward table — exported exactly as published on this page, no reformatting.

Macro Stress-Test: How NBIL Fits In

The book-level stress test runs four scenarios against the whole portfolio. Here is exactly where NBIL sits in each one — named directly, or not addressed at all. Nothing below is invented for this page; it’s the same book-level analysis, filtered to this position.

Current positioning, no shock assumed

NBIL is 2.13% of the book, in the Leveraged Derivative sector. See the full base-case positioning on Holdings.

Where this position sits in the book’s least-defended scenario

Not individually named in the book-level inflation analysis. NBIL contributes to the book’s overall growth-multiple exposure only through its Leveraged Derivative sector weight — see the full scenario on Holdings for what is and isn’t defended.

Not individually assessed

Where this position sits in the book’s best-defended scenario

This is the leveraged sleeve the book-level liquidity analysis calls out directly: capped at 5% of invested capital by the IPS, currently sitting at 2.1% — well under that limit, which specifically caps forced-selling risk in a liquidity event.

The named leveraged sleeve — capped and under-limit

Where this position sits in the book’s largest concentrated risk

Not part of the semiconductor sleeve this scenario is built around. NBIL sits in Leveraged Derivative, so a Taiwan-centered supply disruption would hit this position only indirectly, if at all, through broader market effects.

Outside the named semiconductor exposure